Roy Nofech‐Mozes

430 total citations
8 papers, 357 citations indexed

About

Roy Nofech‐Mozes is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Roy Nofech‐Mozes has authored 8 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Roy Nofech‐Mozes's work include Renal cell carcinoma treatment (6 papers), Renal and related cancers (6 papers) and Ferroptosis and cancer prognosis (3 papers). Roy Nofech‐Mozes is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Renal and related cancers (6 papers) and Ferroptosis and cancer prognosis (3 papers). Roy Nofech‐Mozes collaborates with scholars based in Canada, United States and Hungary. Roy Nofech‐Mozes's co-authors include George M. Yousef, Henriett Butz, Heba Khella, Péter M. Szabó, Attila Patócs, Sergey N. Krylov, Antonio Finelli, Jason Lee, Michael Ordon and Robert Stewart and has published in prestigious journals such as The FASEB Journal, Clinical Chemistry and Journal of Clinical Pathology.

In The Last Decade

Roy Nofech‐Mozes

8 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roy Nofech‐Mozes Canada	7	287	223	126	35	18	8	357
Adina Brett-Morris United States	4	287 1.0×	280 1.3×	144 1.1×	37 1.1×	14 0.8×	6	441
Sabine Harlander Switzerland	7	260 0.9×	171 0.8×	128 1.0×	31 0.9×	20 1.1×	8	342
Zhenhua Li China	11	186 0.6×	113 0.5×	98 0.8×	34 1.0×	32 1.8×	21	319
Chunjuan Zhao China	9	257 0.9×	194 0.9×	44 0.3×	46 1.3×	22 1.2×	12	360
Lifeng Wang China	8	323 1.1×	290 1.3×	47 0.4×	63 1.8×	20 1.1×	18	440
Wanfeng Zhang China	13	257 0.9×	171 0.8×	87 0.7×	50 1.4×	34 1.9×	30	371
Wenxuan Wu China	8	314 1.1×	301 1.3×	114 0.9×	64 1.8×	47 2.6×	14	461
Rose Mary Carletti Italy	6	200 0.7×	198 0.9×	119 0.9×	48 1.4×	28 1.6×	11	338
Jiayan Lian China	8	229 0.8×	190 0.9×	30 0.2×	32 0.9×	17 0.9×	10	304

Countries citing papers authored by Roy Nofech‐Mozes

Since Specialization

Citations

This map shows the geographic impact of Roy Nofech‐Mozes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Nofech‐Mozes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Nofech‐Mozes more than expected).

Fields of papers citing papers by Roy Nofech‐Mozes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Nofech‐Mozes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Nofech‐Mozes. The network helps show where Roy Nofech‐Mozes may publish in the future.

Co-authorship network of co-authors of Roy Nofech‐Mozes

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Nofech‐Mozes. A scholar is included among the top collaborators of Roy Nofech‐Mozes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Nofech‐Mozes. Roy Nofech‐Mozes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Lichner, Zsuzsanna, Rola Saleeb, Henriett Butz, et al.. (2018). Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance. The FASEB Journal. 33(1). 1347–1359. 4 indexed citations

Khella, Heba, Andreas Scorilas, Roy Nofech‐Mozes, et al.. (2017). miR-10b is a prognostic marker in clear cell renal cell carcinoma. Journal of Clinical Pathology. 70(10). 854–859. 31 indexed citations

Butz, Henriett, Qiang Ding, Roy Nofech‐Mozes, et al.. (2017). Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis. Oncotarget. 9(4). 4661–4674. 27 indexed citations

Nofech‐Mozes, Roy, Heba Khella, Andreas Scorilas, et al.. (2016). MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma. Cancer Medicine. 5(4). 656–664. 39 indexed citations

Butz, Henriett, Roy Nofech‐Mozes, Qiang Ding, et al.. (2015). Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell–Cell Communication in Renal Cell Carcinoma. European Urology Focus. 2(2). 210–218. 112 indexed citations

Butz, Henriett, Péter M. Szabó, Heba Khella, et al.. (2015). miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget. 6(14). 12543–12557. 68 indexed citations

Wang, Shuanglian, Allen L. Feng, Tao Li, et al.. (2014). Ethanol induced impairment of glucose metabolism involves alterations of GABAergic signaling in pancreatic β-cells. Toxicology. 326. 44–52. 27 indexed citations

Butz, Henriett, Péter M. Szabó, Roy Nofech‐Mozes, et al.. (2014). Integrative Bioinformatics Analysis Reveals New Prognostic Biomarkers of Clear Cell Renal Cell Carcinoma. Clinical Chemistry. 60(10). 1314–1326. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact